Syra HealthSYRA -3.81%12 EBIT per Share is $-0.02 as of Mar. 2026. GuruFocus rates SYRA with a GF Score™ of 12/100 and a GF Value™ of $0.23 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 528 Healthcare Providers & Services companies, Syra Health ranks better than 77.08% on this metric.
Syra Health's EBIT per Share for the
three
months ended in Mar. 2026 was $0.02.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.02.
During the past 3 years, the average EBIT per Share Growth Rate was 35.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Syra Health's EBIT per Share or its related term are showing as below:
SYRA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 35.8 Med: 35.8 Max: 35.8
Current: 35.8
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Syra Health was 35.80% per year. The lowest was 35.80% per year. And the median was 35.80% per year.
SYRA's 3-Year EBIT Growth Rate is ranked better than 77.08% of 528
companies
in the Healthcare Providers & Services industry
Industry Median: 12
vs SYRA: 35.80
Syra Health's EBIT for the
three
months ended in Mar. 2026 was $0.24 Mil.
Syra Health (OTCPK:SYRA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Syra Health EBIT per Share Related Terms
Syra Health EBIT per Share Historical Data
* Premium members only.
The historical data trend for Syra Health's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syra Health (SYRA) has a EBIT per Share of $-0.02 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Syra Health and its competitors. According to the industry distribution chart, Syra Health ranks #121 out of 528 companies in the Healthcare Providers & Services industry, placing it in the top 22.9%.
Is Syra Health's EBIT per Share too high?
Syra Health's current EBIT per Share is $-0.02. Based on the distribution chart, Syra Health ranks #121 out of 528 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Syra Health has a GF Score™ of 12/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Syra Health's EBIT per Share compare to NIVF and BICX?
According to the Healthcare Providers & Services industry distribution chart, Syra Health ranks #121 out of 528 companies for EBIT per Share. This places Syra Health in the top 23% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 528 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Syra Health and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syra Health's current EBIT per Share is $-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syra Health stock overvalued right now?
Based on GuruFocus' analysis, Syra Health (SYRA) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.23, compared to a current price of $0.70 — trading 205.2% above its estimated fair value. The current EBIT per Share is $-0.02. Syra Health's overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Syra Health (SYRA), the current EBIT per Share is $-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Syra Health (SYRA) Overvalued in 2026?
Based on GuruFocus' analysis, Syra Health stock appears to be overvalued.
The current stock price of $0.70 is trading 205.2% above its estimated GF Value™ of $0.23.
GuruFocus considers Syra Health to be Significantly Overvalued.
Key valuation signals for SYRA:
EBIT per Share: $-0.02
GF Value™: $0.23 vs. price of $0.70 (205.2% above fair value)
No single metric tells the full story. See the SYRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Syra Health Corp is an integrated healthcare solutions company serving government and commercial healthcare organizations. It delivers end-to-end capabilities across population health, behavioral and mental health, digital health, health education and training, and healthcare workforce development and staffing. The various services offered by the company include Syrenity, a mental health application providing preventative care and interventions for behavioral and mental health conditions; SyraBot, a chatbot offering members access to necessary information via the firm's AI-powered customer support chat system; CarePlus, an electronic medical records solution designed for small to mid-sized healthcare organizations; and patient engagement and education services, among others.
12GF Score
Get the complete analysis for SYRA
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SYRA has been successfully added to your 
